ABSTRACT: Aortic stenosis is 1 of the most common heart valve diseases among adults. When symptoms develop, prognosis is poor, and current guidelines recommend prompt aortic valve replacement. Depending of the severity of the aortic stenosis and the presence of concomitant heart disease and medical comorbidities, stress testing represents a reasonable strategy to help better risk stratify asymptomatic patients. The present report provides a comprehensive review of the current available data on stress testing in aortic stenosis and subsequently summarizes its potential for guiding the optimal timing of aortic valve replacement.
A ortic stenosis (AS) is 1 of the most common heart valve diseases in developed countries, affecting 1 in 20 persons >65 years of age. [1] [2] [3] [4] [5] [6] Once symptomatic, the prognosis of AS is extremely poor unless aortic valve replacement (AVR) is performed. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] AVR is therefore recommended by current guidelines for patients with severe AS who are symptomatic (class I indication). 20, 21 Many patients who develop symptoms remain undetected in clinical practice because of lack of follow-up or access to care, or because they have subconsciously, often unconsciously, adapted by decreasing their level of activity to avoid symptoms. They may also not recognize what constitutes significant symptoms, often underestimate their severity, and only report symptoms when they become extremely limiting. Dyspnea, 1 of the most prognostically important symptoms in patients with AS, may be particularly difficult to detect as patients may relate their shortness of breath to other medical conditions or poor stamina. Self-reported symptoms may also be difficult to interpret by treating physicians.
In clinical practice, ≈50% of patients with severe AS report no symptoms at initial diagnosis. [22] [23] [24] [25] Among these patients, irreversible myocardial damage or sudden cardiac death can occur if symptoms are overlooked and treatment is deferred. Similarly, a considerable proportion (≤30%) of patients identified as having moderate AS have been reported to exhibit an abnormal response to exercise, including test-limiting symptoms. 26 Current guidelines recommend AVR (class 1) for patients with spontaneous symptoms or symptoms occurring during a stress test (Table  1) . 20, 21 Stress testing with adjunctive imaging may further unmask other unfavorable characteristics that are not apparent at rest; recent data imply that several of these indices might be useful in risk stratification. [27] [28] [29] [30] [31] [32] [33] [34] [35] The present report will review the available data on stress testing in AS and summarize its potential role in guiding decision making for the optimal timing of AVR. We surveyed the PubMed database through August 31, 2016 , for the search terms listed in Table I in the online-only Data Supplement and manually searched the references of the included articles. Articles pertaining to patients with AS who underwent stress testing were reviewed.
DEFINITION AND DIAGNOSTIC EVALUATION
AS severity is defined by the aortic valve area (AVA) and the velocity of blood flow across the valve as assessed by transthoracic echocardiography. In patients with preserved left ventricular systolic function, severe AS is defined as (1) AVA ≤1.0 cm 2 or AVA index ≤0.6 cm 2 /m 2 , (2) peak aortic jet velocity ≥4.0 m/second, or (3) a mean transvalvular pressure gradient ≥40 mm Hg. Moderate AS is defined as (1) AVA 1.0 to 1.5 cm 2 , (2) peak aortic jet velocity 3.0 to 3.9 m/second, or (3) a mean transvalvular pressure gradient 20 to 39 mm Hg. Mild AS is defined as a peak aortic jet velocity 2.0 to 2.9 m/second. Because AS progression can be unpredictable, it is important to follow patients closely and to be vigilant for the onset of symptoms. 20, 21, 36 Similarly, by acknowledging some of the technical challenges, variability, and discordances in echocardiographic acquisition of currently recommended severity grading criteria, symptoms might develop before classical echocardiographic criteria for severe AS are met. [37] [38] [39] [40] [41] [42] [43] [44] Last, some entity presenting with an AVA <1.0 cm 2 but nonsevere gradient (paradoxical low-flow/low-gradient with normal ejection fraction) may also represent a challenging situation and area of discrepancy in AS severity assessment. 45 
STRESS TESTING IN AS
Stress testing can be performed with exercise or by pharmacological means. Exercise testing is considered more physiological and has considerably stronger support in the medical literature; it is therefore considered the optimal method for risk stratifying patients with AS who are able to exercise. 20, 21 Exercise testing has been demonstrated to be safe for asymptomatic patients with AS. [46] [47] [48] [49] It is important to rule out the following contraindications before performing the test: (1) an established indication for AVR, (2) uncontrolled hypertension, (3) symptomatic or hemodynamically significant arrhythmias, and (4) inability to perform the test such as orthopedic limitations or global disabilities. [50] [51] [52] [53] Typically, a symptom-limited exercise protocol with the goal of reaching 80% to 85% of the age-predicted maximum heart rate is recommended. The most commonly used exercise test in North America and the United Kingdom is the treadmill test. This test is typically performed using a modified Bruce protocol in accordance with the American College of Cardiology/American Heart Association guidelines. 20 Available treadmill stress test protocols are included in Table II in the online-only Data Supplement. In most European Union countries other than the United Kingdom, the most common test is the upright bicycle test. When combined with echocardiography, the test is better performed on a dedicated tilted (semisupine) bicycle.
The traditional symptom-oriented exercise test has been studied most extensively. It is also methodologically relatively simple and can be performed by most cardiologists. The newer complimentary techniques, such as stress echocardiography and cardiopulmonary exercise testing, are more technically demanding and not as well supported; however, they have the potential to add detailed information on valve structure and function as well as the impact of AS on cardiac and other organ function. Although this additional information has been shown to be prognostically important, none has acquired an evidence base that would justify a class I indication for surgery.
Definition of an Abnormal Exercise Test
The definitions of what constitutes serious enough symptoms and signs to qualify for an abnormal stress test differ among reported studies. Typical criteria include AS-related symptoms, a drop or an insufficient rise in blood pressure, significant ventricular arrhythmias, or horizontal or down-sloping ST-depressions; however, many experts do not consider isolated abnormalities in Low-dose dobutamine stress testing using echocardiographic or invasive hemodynamic measurements is reasonable (class IIa per ACC/AHA guidelines) in symptomatic patients presenting with left ventricular ejection fraction <50% and low-flow, low-gradient findings (AVA <1 cm 2 and mean gradient <40 mm Hg or aortic velocity < 4.0 m/second), and clear evidence of a calcific aortic valve with reduced systolic opening.
the ST-segment sufficient for considering the test abnormal. Studies have also been heterogeneous in terms of exercise protocol (Table 2) , [28] [29] [30] [31] 34, 35, [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] study end points (Tables 3 and 4) , [29] [30] [31] [33] [34] [35] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] and patient selection (ie, AS severity) (Tables 2, 3 , and 4). These discrepancies complicate to some extent the interpretation of the available literature.
All 20 publications in Table 3 reported criteria for an abnormal stress test. Exercise-induced symptoms were included in all studies. A fall in systolic blood pressure was also included in all studies. Most studies defined this as a lack of increase or a ≤20 mm Hg increase in systolic blood pressure, but some studies used other definitions. A minority of the studies also stated that the absence of an increase in systolic blood pressure was considered abnormal. Most but not all studies reported that the occurrence of an arrhythmia qualified as an abnormal test; however, the definition of what constituted a significant arrhythmia differed among the studies, and some studies did not provide a definition. Seventeen studies included ischemic ECG changes in the definition of an abnormal stress test. This was typically defined as ≥2 mm ST-depression, but some studies used alternative definitions; however, ST-depression in the context of severe AS and associated left ventricular hypertrophy is, most of the time, nonspecific.
Eighteen of the publications in Table 3 contained information on which symptoms were used to define an abnormal stress test. Angina was reported by all. Dizziness, presyncope, or syncope was also reported by all studies. Dyspnea was reported by most studies, and fatigue was included in a minority of studies. Some studies stated that symptoms had to be limiting or occur at a low workload. Others made no mention of how symptoms such as fatigue and dyspnea were interpreted. Because the focus of most of the manuscripts was on other aspects of AS, only a few sentences were devoted to describing the criteria for an abnormal stress test; therefore, some investigators may have used somewhat different criteria than is implied by their published work. Regardless, it appears that definitions of abnormal stress tests differed across studies, complicating the interpretation of the data.
Acknowledging the inherent difficulty in deciphering between what constitutes AS-related symptoms versus deconditioning, frailty, or other causes of exerciseinduced dyspnea at low workloads, a traditional exercise test should be considered abnormal if the patient experiences AS-related symptoms or displays signs of hemodynamic decompensation. The incidence of an abnormal stress test will vary depending of the severity of AS, ranging from 15% to 65% in the reviewed studies (Tables 2 and 3 ). As many as half of patients with severe asymptomatic AS who undergo exercise testing will have an abnormal stress test (Table 2 ).
Prognostic Implications of the Exercise Test
An abnormal stress test has been consistently shown to be associated with a considerably increased risk of death or adverse events over follow-up. 29, 30, 48, 55, 58 It should be noted that most studies included symptom-driven AVR as an adverse event. Because a positive stress test may lead to referral bias in the form of closer follow-up with a higher likelihood of referring the patient for AVR, the prognostic value of the exercise test in terms of the risk of an adverse event may be overestimated. That being said, a recent meta-analysis reported good sensitivity of a positive exercise test with regard to predicting adverse cardiac events and excellent sensitivity for predicting sudden cardiac death. 48 The specificity of the stress test appears to be lower for older patients (57% for patients ≥70 years versus 79% for patients <70 years), with similar sensitivity. 46 These data clearly demonstrate that many patients with asymptomatic AS are not truly asymptomatic and emphasize the benefit of performing stress testing in these patients who do not report symptoms. It is therefore concerning that relatively few patients with asymptomatic AS undergo routine stress testing. 68 Because the criteria used to define an abnormal stress test differed between the studies and only a few studies reported outcomes according to which criteria were met, it is not clear which exercise-induced sign or symptom carries the most ominous prognosis. However, some data indicate that the development of symptoms has greater prognostic importance than blood pressure or ST-segment abnormalities. 30, 55, 57, 58, 69 It is interesting to note that a recent study showed that poor exercise capacity, defined as percentage of age-and sex-predicted metabolic equivalents achieved, as well as a slow heart rate recovery after exercise, were independently associated with increased mortality among a population of severe AS initially deemed asymptomatic. 27 Pending validation by other studies, these parameters, allowing for a better objective and quantitative stratification of exercise capacity, could be clinically useful. Notwithstanding the differences in definitions of an abnormal test and the uncertainty regarding the relative importance of the different signs and symptoms, the strong association between an abnormal stress test and prognosis makes stress testing an integral part of the risk stratification of patients with AS. 29, 30, 48, 55, 58 Pharmacological Stress Testing in AS One in 6 (≈15%) patients with AS is unable to exercise. 54 Inability to exercise is particularly common among the elderly, in whom the prevalence of AS is the highest. 70 Despite the lack of robust data to support its routine use, pharmacological (dobutamine) stress testing with concomitant cardiac imaging may be considered in these patients. Symptom development after dobutamine 
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administration has been associated with future spontaneous symptom onset in AS. 28 The most commonly used dobutamine stress protocol consists of continuous infusion of dobutamine, starting at 5 μg/kg/minute, with stepwise increase to 10, 20, 30, and 40 μg/kg/minute in 3-minute increments. 46 
Stress Echocardiography in AS
Stress echocardiographic protocols focus on valve or left ventricle (LV)-related parameters and hemodynamics. Stress echocardiography can be performed during exercise or pharmacological stress. Exercise echocardiography is more demanding and requires more training and experience than pharmacological stress echocardiography; it is also considered more physiological and is therefore preferred in patients with asymptomatic AS, whereas dobutamine stress echocardiography is the test of choice for patients with low-gradient, reduced ejection fraction AS that is deemed severe based on AVA calculation. 71 Echocardiography after exercise can be performed after traditional treadmill or bicycle ergometer exercise, but bicycle exercise is the recommended exercise technique when stress echocardiography is performed. With supine or semisupine bicycle stress echocardiography, imaging and Doppler assessment can be performed continuously throughout the testing period. 34 Studies that used stress echocardiography to risk stratify patients with AS are summarized in Table 5 . 27, 28, [30] [31] [32] [33] [34] [35] 56, 61, 66 In moderate or severe AS, a considerable exercise-induced increase in mean pressure gradient is associated with an increased risk of adverse events (cardiac death or development of symptoms, including symptomdriven AVR), with an increase >18 mm Hg or >20 mm Hg considered pathological. 30, 33 Exercise-induced changes *Two hundred and seventy-four stress tests were performed on 104 subjects; 15% of the stress tests were abnormal. †Dobutamine stress echocardiography was also performed, but symptoms were not reported. ‡An additional 4 patients had minor symptoms at high workload. §Symptoms only. in pressure gradient have incremental value over the traditional exercise test and baseline echocardiographic parameters. 30, 33 From a pathophysiological perspective, the increase in pressure gradient during exercise can occur because the AS is severe at baseline, which results in a greater increase in the gradient for a given flow rate during exercise or because the aortic valve is noncompliant and rigid and does not increase its orifice area during stress. 72 Because of the intimate relationship between pressure gradient and flow rate, exercise-induced changes in gradient should be interpreted in the context of changes in stroke volume. If the stroke volume increases markedly during exercise, then the gradient can increase considerably even in the presence of a compliant valve. Assessment of exercise-induced changes in stroke volume has additional value because the change AS indicates aortic stenosis; AVA, aortic valve area; BNP, B-type natriuretic peptide, CP, cardiopulmonary exercise testing performed; E, diastolic mitral inflow velocity; e', peak diastolic mitral annulus velocity; FEV 1 , forced expiratory volume in 1 second; LVEF, left ventricular ejection fraction; MET, metabolic equivalent; N/A, not available; ΔP, pressure gradient; pVO 2 , peak oxygen consumption; SBP, systolic blood pressure; SE, stress echocardiography performed; Vco 2 , carbon dioxide elimination rate; VE/CO 2 , ventilatory equivalent for carbon dioxide; and Vo 2 , oxygen uptake rate. Correlates of reduced pVO 2 were low stroke volume, low peak heart rate, low FEV 1 decreased VE/VCO 2 , mean ΔP, AVA index, E/e', and elevated BNP AS indicates aortic stenosis; AVA, aortic valve area; BNP, B-type natriuretic peptide; CP, cardiopulmonary exercise testing performed; E, diastolic mitral inflow velocity; e', peak diastolic mitral annulus velocity; FEV 1 , forced expiratory volume in 1 second; LVEF, left ventricular ejection fraction; MET, metabolic equivalent; ΔP, pressure gradient; pVO 2 , peak oxygen consumption; SBP, systolic blood pressure; SE, stress echocardiography performed; Vco 2 , carbon dioxide elimination rate; VE/CO 2 , ventilatory equivalent for carbon dioxide; and Vo 2 , oxygen uptake rate. in stroke volume is a prognostic marker in AS. The absence of an exercise-induced increase in stroke volume or ejection fraction is considered abnormal and associated with reduced cardiac event-free survival (with cardiovascular death and AVR constituting an event). 30, 31, 33 Beyond pressure gradient and left ventricular functional parameters, 2 novel exercise echocardiographic indices are emerging. First, development of pulmonary hypertension (systolic pulmonary arterial pressure >60 mm Hg) at peak exercise has been associated with a 2-fold increased adjusted risk of cardiac events (cardiovascular death or need for AVR due to symptoms or LV dysfunction). 66 Whereas pulmonary hypertension at baseline is a strong predictor of worse outcomes even if the patient undergoes AVR, and is often associated with symptoms, pulmonary hypertension that develops only during exercise represents an earlier disease stage. Intervention before chronic pulmonary hypertension develops may improve prognosis. Second, impaired global longitudinal strain (using various cutoffs values as well as a linear metric) has been observed in patients with severe AS and is believed to reflect subendocardial cardiomyocyte dysfunction secondary to concentric remodeling and myocardial fibrosis. 59, 69, [73] [74] [75] Recently, the magnitude of exercise-induced changes in global longitudinal strain, as assessed by tissue Doppler imaging or 2-dimensional speckle-tracking, predicted reduced contractile reserve; however, these studies did not examine the relationship between exercise-induced changes in global longitudinal strain and clinical events. 34, 76 Hence, the association between changes in global longitudinal strain during exercise and clinical outcomes needs to be confirmed.
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In summary, among asymptomatic AS patients, exercise echocardiography is a diagnostic modality that has the potential for continuous assessment during exercise of key parameters related to valve anatomy and physiology. It appears to offer incremental value over the traditional exercise test and baseline echocardiography, but its value in asymptomatic AS needs to be proven in more robust studies. The European Society of Cardiology/European Association for Cardio-Thoracic Surgery but not the American College of Cardiology/American Heart Association guidelines recommend that for asymptomatic severe AS patients with normal ejection fraction and high gradient, AVR could be considered for patients with >20 mm Hg increase in mean gradient during exercise (class IIb). 21 
Cardiopulmonary Exercise Testing in AS
Cardiopulmonary exercise testing complements the traditional stress test by adding information on respiratory gas exchange, including maximum oxygen uptake (Vo 2 ). This is achieved by measuring airflow rates (transducers) and the partial pressures of O 2 and CO 2 (gas analyzers). 77, 78 Maximum Vo 2 reflects the body's highest attainable rate of transport and use of oxygen. Thus, in AS the maximum Vo 2 reflects the impact of AS on the heart's primary objective, the delivery of oxygen and nutrients to the tissues. A strong association between maximum Vo 2 and the risk of adverse clinical outcomes has been demonstrated in other forms of heart failure. 79 In a study by Dulgheru et al, 62 ≈50% of patients with asymptomatic severe AS had markedly reduced Vo 2 (defined as <84% of the age-and sex-predicted peak Vo 2 ). van Le et al 65 performed cardiopulmonary exercise testing in 130 patients with asymptomatic or equivocally asymptomatic moderate or severe AS (AVA <1.3 cm 2 ). Patients with Vo 2 <83% of the predicted value and in whom the reduced Vo 2 could only be explained by the AS were referred to an independent heart team for possible AVR. Cardiopulmonary exercise testing was safe, and subsequent adverse event rates were low; however, the study design (patients were referred to AVR based on their maximum Vo 2 value) complicates interpretation of the value of the cardiopulmonary exercise test. The relationship between decreased Vo 2 and other cardiopulmonary exercise parameters with clinical outcomes needs to be addressed.
Neurohormones During Exercise Testing in AS
Plasma B-type natriuretic peptide concentration at baseline is a complimentary tool to exercise testing for risk stratifying patients with AS. [80] [81] [82] [83] A recent study in 211 patients showed that increased peak-exercise plasma B-type natriuretic peptide levels are independently associated with adverse outcomes among asymptomatic patients with AS. 67 Similarly, baseline cardiospecific troponin levels are associated with worse prognosis in AS, and troponin levels after stress correlate with myocardial ischemia in patients with coronary artery disease. [84] [85] [86] Additional studies are required to establish whether Btype natriuretic peptide, troponin, or other biomarkers measured at peak exercise have a role in the risk stratification of patients with AS.
Limitations of Exercise Testing in AS
An inherent limitation with the exercise test is that the symptoms and signs that may develop during exercise are not specific for AS, and exercise capacity can be influenced to varying degrees by other cardiac or noncardiac conditions. [87] [88] [89] Concomitant coronary artery disease is common among patients with AS and increases with age. 87 Whether symptoms such as chest pain and dyspnea are caused predominantly by the coronary obstruction or the AS is difficult to discern. Similarly, chronic obstructive pulmonary disease may cause these symptoms. 88, 89 Exercise echocardiography and cardiopulmonary imaging can provide more disease-specific information that may help to differentiate between AS and non-AS-related symptoms. 30 . However, it is not possible to fully exclude the possibility that concomitant diseases contribute considerably to the symptomatology and results of an exercise test. That being said, it may be reasonable to treat the AS in many situations where concomitant disease contributes to patient symptomatology because effective treatment of significant AS is likely to provide symptom relief in the setting of concomitant disease. 98 
THE ROLE OF STRESS TESTING IN CLINICAL DECISION MAKING
The most important decision a physician faces when caring for a patient with asymptomatic AS is when to recommend AVR. 20, 21 Traditional symptom-limited exercise testing is helpful to determine whether patients with severe AS and preserved LV systolic function who do not report symptoms are truly asymptomatic. Asymptomatic patients with severe AS and reduced or subnormal LV systolic function should be referred for surgery (class I). If the patient with preserved LV function develops spontaneous valve-related symptoms during follow-up or exercise stress testing, then both European Society of Cardiology/European Association for Cardio-Thoracic Surgery and American College of Cardiology/American Heart Association guidelines recommend referral for AVR (class I). If an abnormal physiological response such as a lack of blood pressure increase or ventricular arrhythmia occurred during exercise stress testing, then AVR is recommended (class IIa). 20, 21 Exercise testing should be considered in any asymptomatic patient with severe AS and preserved LV systolic function, especially if there is a concern regarding the accuracy of the history or a need to establish the safety of daily physical activities or occupational work. If the patient is unable to perform an exercise test, then other stratification methods, such as baseline and follow-up biomarkers (eg, B-type natriuretic peptide), could be useful.
If the exercise test is normal (the patient does not report symptoms or fulfills the other criteria for an abnormal test), then a short-term prognosis is reasonable, and clinical/echocardiographic follow-up can continue per current guidelines. Recognition and reporting of symptoms between visits is essential to reduce not only the risk of sudden cardiac death (which is low among this population), but also disease progression, irreversible myocardial damage, and the development of other major complications, including atrial fibrillation and heart failure hospitalization. Current guidelines recommend repeat echocardiography every 6 to 12 months for severe AS and every 12 to 24 months for moderate AS but are silent as to whether an exercise test should be repeated at each follow-up. 20, 21 Given the variability in symptom reporting and the assiduousness of clinical follow-up, repeat stress testing could be seen as reasonable. Exercise echocardiography and cardiopulmonary exercise testing may add incremental prognostic information, and high-risk features such as an exerciseinduced increase in mean pressure gradient ≥20 mm Hg may motivate closer follow-up. 33, 99 In fact, given the currently low procedural mortality and morbidity rates for isolated surgical AVR and transcatheter AVR, earlier intervention may be favorable for at least a subset of these patients. 15, 16, [100] [101] [102] As discussed earlier, the European Society of Cardiology/European Association for Cardio-Thoracic Surgery guidelines acknowledge that AVR can be considered for patients in whom the mean gradient increases by ≥20 mm Hg during exercise (class IIb). 21 Further studies are needed to confirm these asso- ACC/AHA indicates American College of Cardiology/American Heart Association; AS, aortic stenosis; AVR, aortic valve replacement; BP, blood pressure; ESC, European Society of Cardiology; LVEF, left ventricular ejection fraction; and MG, mean gradient. ciations and develop criteria or risk scores for predicting prognosis in asymptomatic patients who perform well on exercise testing. Ideally, future large-scale randomized controlled trials comparing AVR to a conservative approach may help identify asymptomatic patients for whom intervention can be justified.
Last, given the inherent limitations and challenges of the current anatomic and valve-centric grading system (mild, moderate, severe) and the poor prognosis associated with a positive stress test among patients with moderate or severe AS, 103 a multimodal stratification scheme incorporating both anatomic (echocardiogram) grading criteria and physiological (stress test) assessment of AS might represent a more appropriate investigational strategy when facing patients with severe or even moderate asymptomatic AS. Advantages of such a novel and more aggressive strategy in which early screening of potential AVR candidate is performed using a multimodal approach includes the balancing of intrinsic limitations associated with each modality and the identification of early AS-related repercussions not captured by more conventional anatomic criteria. Further prospective studies are needed to validate such approach ( 
CONCLUSIONS
Approximately half of patients diagnosed with severe AS do not report symptoms. Exercise testing is helpful to identify whether patients are truly asymptomatic. Traditional treadmill exercise testing or bicycle ergometer are safe, and it is well established that patients with AS and an abnormal exercise test have a worse prognosis unless AVR is performed. Exercise echocardiography and cardiopulmonary exercise testing can complement the traditional symptom-based exercise test with detailed information on valve structure and function and capacity for adequate oxygen delivery, but more experience with these techniques is necessary.
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